These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 7512888)
1. Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients. Liberati AM; De Angelis V; Fizzotti M; Schippa M; Cecchini M; Adiuto D; Di Clemente F; Palmisano L; Micozzi E; Zuccaccia M Cancer Immunol Immunother; 1994 May; 38(5):323-31. PubMed ID: 7512888 [TBL] [Abstract][Full Text] [Related]
2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation. Reiter Z; Tomson S; Ozes ON; Taylor MW Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405 [TBL] [Abstract][Full Text] [Related]
4. CD16- CD56+ natural killer cells after bone marrow transplantation. Jacobs R; Stoll M; Stratmann G; Leo R; Link H; Schmidt RE Blood; 1992 Jun; 79(12):3239-44. PubMed ID: 1375847 [TBL] [Abstract][Full Text] [Related]
5. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2. Reiter Z; Ozes ON; Blatt LM; Taylor MW J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947 [TBL] [Abstract][Full Text] [Related]
6. Discordant effect of interferon on natural killer activity and tumor cell sensitivity to lysis in hairy cell leukemia. Lahat N; Aghai E; Kotler A; Kinarty A; Sobel E; Gruener N; Froom P Blood; 1988 Apr; 71(4):1141-3. PubMed ID: 3258536 [TBL] [Abstract][Full Text] [Related]
7. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057 [TBL] [Abstract][Full Text] [Related]
8. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients. Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067 [TBL] [Abstract][Full Text] [Related]
9. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211 [TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2. Hellstrand K; Hermodsson S Int Arch Allergy Appl Immunol; 1990; 92(4):379-89. PubMed ID: 2150668 [TBL] [Abstract][Full Text] [Related]
11. The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha. Cordero OJ; Sarandeses C; López-Rodríguez JL; Nogueira M Immunopharmacology; 1995 Apr; 29(3):215-23. PubMed ID: 7542644 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974 [TBL] [Abstract][Full Text] [Related]
13. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients. Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440 [TBL] [Abstract][Full Text] [Related]
14. Lower concentrations of methyl-β-cyclodextrin combined with interleukin-2 can preferentially induce activation and proliferation of natural killer cells in human peripheral blood. Lü HZ; Zhu AY; Chen Y; Tang J; Li BQ Hum Immunol; 2011 Jul; 72(7):538-46. PubMed ID: 21540068 [TBL] [Abstract][Full Text] [Related]
15. Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations. Franzese O; Tricarico M; Starace G; Pepponi R; Bonmassar L; Cottarelli A; Fuggetta MP J Interferon Cytokine Res; 2013 Jun; 33(6):308-18. PubMed ID: 23421371 [TBL] [Abstract][Full Text] [Related]
17. Immunological changes in peripheral blood mononuclear cells of patients with metastatic renal cell carcinoma after low doses of subcutaneous immunotherapy with IFN-alpha-2b and IL-2. Moltó L; Carballido J; Manzano L; Martinez-Martin B; Esquivel F; Chafer J; Olivier C; Alvarez-Mon M J Immunother; 1999 May; 22(3):260-7. PubMed ID: 10335486 [TBL] [Abstract][Full Text] [Related]
18. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298 [TBL] [Abstract][Full Text] [Related]
19. A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity. Reiter Z; Ozes ON; Blatt LM; Taylor MW Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):103-11. PubMed ID: 1370257 [TBL] [Abstract][Full Text] [Related]
20. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-alpha. Kutza J; Murasko DM Cell Immunol; 1994 Apr; 155(1):195-204. PubMed ID: 7513259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]